Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Lidocaine | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Lidocaine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | | Lidocaine | hsa00250 | Alanine, aspartate and glutamate metabolism | 8.48E-03 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Lidocaine | hsa00270 | Cysteine and methionine metabolism | 2.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | | Lidocaine | hsa00280 | Valine, leucine and isoleucine degradation | 8.40E-05 | 6 | P55809, Q9HCC0, Q96RQ9, P05166, Q02252, P11310 | OXCT1, MCCC2, IL4I1, PCCB, ALDH6A1, ACADM | More | | Lidocaine | hsa00310 | Lysine degradation | 4.50E-02 | 2 | Q9NVH6, O15047 | TMLHE, SETD1A | More | | Lidocaine | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Lidocaine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.20E-07 | 4 | P40925, P40926, P05166, P15104 | MDH1, MDH2, PCCB, GLUL | More | | Lidocaine | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Lidocaine | hsa00983 | Drug metabolism - other enzymes | 2.07E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Lidocaine | hsa01100 | Metabolic pathways | 2.28E-03 | 21 | Q9UJ14, P30041, P15104, Q96DU7, Q08828, Q02153, P20839, P40926, P08237, Q86XP1, Q96RQ9, Q9UHK6, Q86VZ5, Q9H4F1, Q9BRR6, P05166, P12074, P05496, O15239, O15047, Q9NVH6 | GGTL3, PRDX6, GLUL, ITPKC, ADCY1, GUCY1B3, IMPDH1, MDH2, PFKM, DGKH, IL4I1, AMACR, SGMS1, ST6GALNAC4, ADPGK, PCCB, COX6A1, ATP5G1, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | -0.717 | O95931 | CBX7 | Chromobox protein homolog 7 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.72 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P15104 | GLUL | Glutamine synthetase | -0.718 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | 0.879 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q08828 | ADCY1 | Adenylate cyclase type 1 | -0.748 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | 0.847 | O95931 | CBX7 | Chromobox protein homolog 7 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.771 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | -0.731 | O95931 | CBX7 | Chromobox protein homolog 7 | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.702 | O95931 | CBX7 | Chromobox protein homolog 7 | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.726 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q86XP1 | DGKH | Diacylglycerol kinase eta | 0.804 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q96RQ9 | IL4I1 | L-amino-acid oxidase | 0.761 | O95931 | CBX7 | Chromobox protein homolog 7 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.798 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.839 | O95931 | CBX7 | Chromobox protein homolog 7 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.762 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | -0.785 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9BRR6 | ADPGK | ADP-dependent glucokinase | -0.71 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05166 | PCCB | Propionyl-CoA carboxylase beta chain, mitochondrial | -0.714 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.715 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.815 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.834 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | -0.831 | O95931 | CBX7 | Chromobox protein homolog 7 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.731 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | 0.74 |
| Lidocaine | hsa01522 | Endocrine resistance | 4.07E-04 | 5 | P14780, P22694, Q9UM47, P10415, Q13323 | MMP9, PRKACB, NOTCH3, BCL2, BIK | More | | Lidocaine | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Lidocaine | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Lidocaine | hsa03013 | RNA transport | 4.13E-02 | 6 | Q09161, P35658, P47813, Q14152, O75822, P51114 | NCBP1, NUP214, EIF1AX, EIF3A, EIF3J, FXR1 | More | | Lidocaine | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Lidocaine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Lidocaine | hsa03040 | Spliceosome | 8.73E-04 | 8 | Q14562, O43143, O60508, P08579, Q07955, Q01130, Q13243, O43447 | DHX8, DHX15, CDC40, SNRPB2, SFRS1, SFRS2, SFRS5, PPIH | More | | Lidocaine | hsa03450 | Non-homologous end-joining | 4.48E-03 | 1 | P78527 | PRKDC | More | | Lidocaine | hsa04024 | cAMP signaling pathway | 4.38E-02 | 4 | P42338, P0DP23, Q13370, Q13009 | PIK3CB, CALM1, PDE3B, TIAM1 | More | | Lidocaine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Lidocaine | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Lidocaine | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | | Lidocaine | hsa04070 | Phosphatidylinositol signaling system | 3.21E-03 | 5 | P0DP23, P42338, Q86XP1, P27987, Q96DU7 | CALM1, PIK3CB, DGKH, ITPKB, ITPKC | More | | Lidocaine | hsa04071 | Sphingolipid signaling pathway | 1.70E-03 | 5 | Q9H228, P01375, Q13362, Q9BX95, P10415 | EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Lidocaine | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Lidocaine | hsa04110 | Cell cycle | 1.35E-02 | 1 | P78527 | PRKDC | More | | Lidocaine | hsa04137 | Mitophagy - animal | 3.55E-04 | 4 | Q96CV9, Q9H1Y0, P18848, O43524 | OPTN, ATG5, ATF4, FOXO3 | More | | Lidocaine | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Lidocaine | hsa04146 | Peroxisome | 4.38E-03 | 4 | O43933, O96011, P56589, P33121 | PEX1, PEX11B, PEX3, ACSL1 | More | | Lidocaine | hsa04213 | Longevity regulating pathway - multiple species | 4.41E-03 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Lidocaine | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | | Lidocaine | hsa04330 | Notch signaling pathway | 1.30E-04 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Lidocaine | hsa04360 | Axon guidance | 1.71E-02 | 4 | P20827, O95631, P42338, P23528 | EFNA1, NTN1, PIK3CB, CFL1 | More | | Lidocaine | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Lidocaine | hsa04613 | Neutrophil extracellular trap formation | 6.84E-08 | 22 | P11215, O60603, P05164, P08246, Q9UM07, Q13547, P04908, Q6FI13, Q93077, P58876, Q16778, O60814, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Lidocaine | hsa04621 | NOD-like receptor signaling pathway | 2.77E-03 | 8 | Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Lidocaine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Lidocaine | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Lidocaine | hsa04650 | Natural killer cell mediated cytotoxicity | 2.48E-03 | 8 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3 | More | | Lidocaine | hsa04657 | IL-17 signaling pathway | 1.14E-03 | 7 | P07900, O00463, Q16539, P49841, P14780, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, MMP9, TNF, IL1B | More | | Lidocaine | hsa04658 | Th1 and Th2 cell differentiation | 2.21E-04 | 8 | Q04759, P07766, P20963, P19174, P06239, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, TBX21, IL2RB, RUNX3 | More | | Lidocaine | hsa04659 | Th17 cell differentiation | 1.89E-04 | 11 | Q04759, P19174, P06239, P42224, P14784, P14778, P40189, Q9UL17, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, IL1R1, IL6ST, TBX21, HSP90AB1, CD3E, CD247 | More | | Lidocaine | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | | Lidocaine | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Lidocaine | hsa04664 | Fc epsilon RI signaling pathway | 2.20E-03 | 6 | P01375, Q16539, P42338, Q9UQC2, P07948, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, ALOX5 | More | | Lidocaine | hsa04666 | Fc gamma R-mediated phagocytosis | 3.08E-02 | 3 | P42338, P23528, P14598 | PIK3CB, CFL1, NCF1 | More | | Lidocaine | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Lidocaine | hsa04713 | Circadian entrainment | 9.20E-03 | 4 | Q13557, Q02153, P61952, Q08828 | CAMK2D, GUCY1B3, GNG11, ADCY1 | More | | Lidocaine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Lidocaine | hsa04724 | Glutamatergic synapse | 5.94E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Lidocaine | hsa04725 | Cholinergic synapse | 4.10E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Lidocaine | hsa04727 | GABAergic synapse | 4.58E-04 | 6 | Q08828, P63218, P50151, P61952, P15104, Q15111 | ADCY1, GNG5, GNG10, GNG11, GLUL, PLCL1 | More | | Lidocaine | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Lidocaine | hsa04911 | Insulin secretion | 3.04E-02 | 3 | Q08828, Q99941, Q13557 | ADCY1, CREBL1, CAMK2D | More | | Lidocaine | hsa04914 | Progesterone-mediated oocyte maturation | 3.92E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Lidocaine | hsa04919 | Thyroid hormone signaling pathway | 3.71E-02 | 2 | P26678, P08237 | PLN, PFKM | More | | Lidocaine | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Lidocaine | hsa04924 | Renin secretion | 3.77E-02 | 2 | Q13370, P0DP23 | PDE3B, CALM1 | More | | Lidocaine | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P49407 | PIK3CB, GNG5, GNG10, VEGFC, ARRB1 | More | | Lidocaine | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Lidocaine | hsa04932 | Non-alcoholic fatty liver disease | 9.01E-04 | 7 | P49841, P18848, P01584, P13073, O15239, Q16718, O14521 | GSK3B, ATF4, IL1B, COX4I1, NDUFA1, NDUFA5, SDHD | More | | Lidocaine | hsa04934 | Cushing syndrome | 9.20E-03 | 4 | Q99941, Q08828, O15169, Q13557 | CREBL1, ADCY1, AXIN1, CAMK2D | More | | Lidocaine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Lidocaine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Lidocaine | hsa05010 | Alzheimer disease | 2.41E-02 | 8 | P49768, Q92542, O15239, P05496, P12074, Q12933, O15169, P43686 | PSEN1, NCSTN, NDUFA1, ATP5G1, COX6A1, TRAF2, AXIN1, PSMC4 | More | | Lidocaine | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Lidocaine | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Lidocaine | hsa05020 | Prion disease | 3.73E-04 | 11 | P13591, P01584, P11142, O15239, Q16718, O14521, P13073, P18848, P05141, P49841, Q16539 | NCAM1, IL1B, HSPA8, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, SLC25A5, GSK3B, MAPK14 | More | | Lidocaine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.24E-05 | 20 | P49841, O15239, Q16718, O14521, P13073, P12074, P05496, P18848, Q12933, Q13561, P05141, Q16539, O15169, P01584, P49768, Q08752, O15020, Q13557, P62987, P43686 | GSK3B, NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, ATP5G1, ATF4, TRAF2, DCTN2, SLC25A5, MAPK14, AXIN1, IL1B, PSEN1, PPID, SPTBN2, CAMK2D, UBA52, PSMC4 | More | | Lidocaine | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Lidocaine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Lidocaine | hsa05131 | Shigellosis | 3.32E-03 | 9 | P01375, O00463, Q04759, Q9UDY8, Q9H1Y0, P20810, O43524, P10415, Q96A32 | TNF, TRAF5, PRKCQ, MALT1, ATG5, CAST, FOXO3, BCL2, MYLPF | More | | Lidocaine | hsa05134 | Legionellosis | 6.38E-04 | 6 | P01584, P11215, P68104, P11142, P09341, P19875 | IL1B, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | | Lidocaine | hsa05144 | Malaria | 9.55E-04 | 4 | O60603, P01375, P35443, P26718 | TLR2, TNF, THBS4, KLRK1 | More | | Lidocaine | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | | Lidocaine | hsa05150 | Staphylococcus aureus infection | 6.42E-05 | 8 | P21730, P21462, O75015, Q14532, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Lidocaine | hsa05152 | Tuberculosis | 7.83E-04 | 7 | O75015, P48382, O60603, P01375, P10415, P49913, Q9UDY8 | FCGR3B, RFX5, TLR2, TNF, BCL2, CAMP, MALT1 | More | | Lidocaine | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Lidocaine | hsa05163 | Human cytomegalovirus infection | 2.80E-02 | 6 | P01375, P49841, P14778, P25025, Q16539, O00463 | TNF, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Lidocaine | hsa05168 | Herpes simplex virus 1 infection | 1.15E-02 | 8 | P42224, Q07955, Q01130, Q13243, P42338, Q13398, Q03923, Q9UDV6 | STAT1, SFRS1, SFRS2, SFRS5, PIK3CB, ZNF211, ZNF85, ZNF212 | More | | Lidocaine | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Lidocaine | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Lidocaine | hsa05200 | Pathways in cancer | 3.92E-02 | 9 | P42338, P08238, P42224, P43246, P14923, O75293, P0DP23, P14784, P40189 | PIK3CB, HSP90AB1, STAT1, MSH2, JUP, GADD45B, CALM1, IL2RB, IL6ST | More | | Lidocaine | hsa05202 | Transcriptional misregulation in cancer | 1.24E-02 | 4 | P27930, P11215, Q13547, P12980 | IL1R2, ITGAM, HDAC1, LYL1 | More | | Lidocaine | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Lidocaine | hsa05212 | Pancreatic cancer | 1.72E-02 | 3 | P42338, P42224, O75293 | PIK3CB, STAT1, GADD45B | More | | Lidocaine | hsa05214 | Glioma | 1.72E-02 | 3 | P0DP23, P42338, O75293 | CALM1, PIK3CB, GADD45B | More | | Lidocaine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Lidocaine | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | | Lidocaine | hsa05415 | Diabetic cardiomyopathy | 1.02E-03 | 8 | P05141, O15239, Q16718, O14521, P13073, Q16539, P49841, Q13557 | SLC25A5, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, GSK3B, CAMK2D | More | | Lidocaine | hsa05418 | Fluid shear stress and atherosclerosis | 1.40E-04 | 11 | Q16539, P42338, Q14145, P14598, P10599, P14780, P01375, P14778, P27930, P0DP23, P08238 | MAPK14, PIK3CB, KEAP1, NCF1, TXN, MMP9, TNF, IL1R1, IL1R2, CALM1, HSP90AB1 | More | | |